FDA official who approved OxyContin got $400,000 gig at Purdue Pharma a year later GOVERNMENT OFFICIAL FOR SALE — May 2, 2021 - Purdue Pharma's sale of OxyContin, a formulation of the narcotic oxycodone that was said to slow down the release of the strong painkiller when taken as prescribed, h... Read More...Addiction RecoveryBig PharmaDrug Abuse and AddictioninterventionMay 4 2021opioid crisisopioidsoxycontinPurdue Pharma